Literature DB >> 2040872

Impaired blood rheology: a risk factor after stroke?

E Ernst1, K L Resch, A Matrai, M Buhl, P Schlosser, H F Paulsen.   

Abstract

The hypothesis that blood rheology is of prognostic value in stroke patients was tested in a prospective study. A total of 523 patients in the rehabilitation phase of stroke (outside the acute phase reaction after stroke) were tested for blood, serum and plasma viscosity, haematocrit, fibrinogen, red cell aggregation and deformability, ESR, white cell count, cholesterol and triglycerides. Endpoints were defined as a second stroke (lethal or not) within 2 years after the initial examination. Patients suffering such endpoints exhibit elevated blood viscosity, red cell aggregation, plasma and serum viscosity, fibrinogen and cholesterol levels, compared to patients without endpoints. It is concluded that rheological factors are associated with the prognosis after a first stroke.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040872     DOI: 10.1111/j.1365-2796.1991.tb00375.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  4 in total

1.  Fibrinogen.

Authors:  E Ernst
Journal:  BMJ       Date:  1991-09-14

2.  Optical coherence tomography for evaluating capillary waves in blood and plasma.

Authors:  Hsiao-Chuan Liu; Piotr Kijanka; Matthew W Urban
Journal:  Biomed Opt Express       Date:  2020-01-24       Impact factor: 3.732

3.  Protective effects of traditional Chinese medicine formula NaoShuanTong capsule on haemorheology and cerebral energy metabolism disorders in rats with blood stasis.

Authors:  Hong Liu; Yao-Yao Peng; Feng-Yin Liang; Si Chen; Pei-Bo Li; Wei Peng; Zhong-Zheng Liu; Cheng-Shi Xie; Chao-Feng Long; Wei-Wei Su
Journal:  Biotechnol Biotechnol Equip       Date:  2014-01-02       Impact factor: 1.632

4.  Whole blood viscosity is associated with baseline cerebral perfusion in acute ischemic stroke.

Authors:  Prajwal Gyawali; Thomas Patrick Lillicrap; Shinya Tomari; Andrew Bivard; Elizabeth Holliday; Mark Parsons; Christopher Levi; Carlos Garcia-Esperon; Neil Spratt
Journal:  Neurol Sci       Date:  2021-10-20       Impact factor: 3.830

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.